Envestnet Asset Management Inc. reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 30.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,331 shares of the company's stock after selling 70,268 shares during the period. Envestnet Asset Management Inc. owned about 0.09% of Option Care Health worth $3,719,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Wells Fargo & Company MN grew its stake in shares of Option Care Health by 9.5% in the 4th quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock valued at $4,185,000 after buying an additional 15,609 shares in the last quarter. Landscape Capital Management L.L.C. grew its position in Option Care Health by 102.3% in the fourth quarter. Landscape Capital Management L.L.C. now owns 29,775 shares of the company's stock worth $691,000 after acquiring an additional 15,055 shares in the last quarter. ExodusPoint Capital Management LP raised its holdings in shares of Option Care Health by 167.8% during the 4th quarter. ExodusPoint Capital Management LP now owns 54,810 shares of the company's stock valued at $1,272,000 after purchasing an additional 34,340 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of Option Care Health in the 4th quarter valued at $10,161,000. Finally, Headlands Technologies LLC bought a new stake in Option Care Health in the fourth quarter worth $359,000. Hedge funds and other institutional investors own 98.05% of the company's stock.
Option Care Health Stock Performance
Option Care Health stock traded down $1.48 during trading hours on Tuesday, hitting $31.49. The stock had a trading volume of 3,346,659 shares, compared to its average volume of 1,787,801. The company has a market cap of $5.17 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a 50-day moving average of $33.37 and a two-hundred day moving average of $28.78.
Analysts Set New Price Targets
Several research firms have recently issued reports on OPCH. JMP Securities reiterated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Monday, April 21st. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.75.
Check Out Our Latest Analysis on Option Care Health
Insider Buying and Selling at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company's stock.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
